{"id":3748,"date":"2019-05-08T11:50:23","date_gmt":"2019-05-08T11:50:23","guid":{"rendered":"http:\/\/snpcar.ro\/?p=3748"},"modified":"2019-05-08T11:50:53","modified_gmt":"2019-05-08T11:50:53","slug":"aspecte-clinice-in-sindromul-dravet-ce-stim-dupa-40-de-ani-de-la-prima-descriere","status":"publish","type":"post","link":"https:\/\/snpcar.ro\/en\/aspecte-clinice-in-sindromul-dravet-ce-stim-dupa-40-de-ani-de-la-prima-descriere.htm","title":{"rendered":"Clinical aspects in Dravet syndrome, what do we know 40 years after first description"},"content":{"rendered":"<p>SUMMARY<br \/>\nDravet syndrome was described 40 years ago (1978) by Charlotte Dravet under the name of severe myoclonic epilepsy in infancy (SMEI). It is an epileptic encephalopathy characterized by seizures, beginning in the first year of life in the form of prolonged febrile seizures; in a child with no previous personal history of neurological disease; epilepsy or febrile convulsions are present in family history. Other type of seizures appear later in evolution and other neurological symptoms: ataxia, pyramidal signs, intellectual deficiency and personality disorders. It is a genetic, resistant form of epilepsy and it has high impact on the child, families and medical system. Its management needs a multidisciplinary team, due to complex symptoms and high risk of morbidity and mortality. Dravet syndrome must be kept in mind in every infant presented in ER with previous mentioned symptoms, correct diagnosis could avoid fatal mistakes and assure the most proper management for these children.<br \/>\nKeywords: Dravet syndrome, encephalopathy, childhood, adult<\/p>\n<p>BACKGROUND<br \/>\nSynonims:<br \/>\nDravet syndrome (DS),<br \/>\nEpilepsy with polymorphic seizures, Polymorphic epilepsy in infancy (PMEI), Severe myoclonic epilepsy in infancy (SMEI).<br \/>\nDravet syndrome spectrum:<br \/>\n\u2013\tDravet syndrome<br \/>\n\u2013\tFebrile seizures<br \/>\n\u2013\tGenetic epilepsy with febrile seizures plus (GEFS+)<br \/>\n\u2013\tEpilepsy with mental retardation limited to females (EMRF)<br \/>\n\u2013\tIntractable childhood epilepsy with GTCs (ICE-GTC)<br \/>\n\u2013\tSevere myoclonic epilepsy borderline (SMEB)<br \/>\nDEFINITIONS<br \/>\nDravet syndrome was described in 1978 by Charlotte Dravet under the name of severe myoclonic epilepsy in infancy (SMEI) [1]. Later, it was showed that epilepsy was not limited to infancy or childhood, but continued through adulthood, so the name \u2018\u2018Dravet syndrome\u2019\u2019 was proposed (Commission on Classification and Terminology of the International League Against Epilepsy, 1989) [2]. In the latest ILAE<br \/>\nclassification for epilepsies and epileptic syndromes (2017), DS is included in generalized epilepsies with genetic etiology [3]. Bordeline DS is defined as<br \/>\n\u201eepilepsy with clinical characteristics as those in DS but lacking epileptic myioclonic seizures and atypical absence seizures\u201d [4].<br \/>\nSites<br \/>\nOMIM 54 607208<br \/>\nDisease Ontology 12 DOID:0060171<br \/>\nOrphanet 56 ORPHA3306ICD10 via Orphanet 34 G40.4<br \/>\nMedGen 40 C0751122 C3501832 MeSH 42 D004831<br \/>\nIs DS an epileptic encephalopathy?<br \/>\nDS has been considered \u2018epileptic encephalopathy\u2019 in previous International League Against Epilepsy classification [5].<br \/>\nThe term epileptic encephalopathy is defined by<br \/>\nBerg et al. (2010) \u201cas where the epileptic activity itself contributes to severe cognitive and behavioral impairments above and beyond what might be expected from the underlying pathology alone (e.g., cortical malformation). Global or selective cognitive impairments can worsen over time.These impairments can be seen along a spectrum of severity and across all epilepsies and can occur at any age\u201d [6].<br \/>\nThe latest ILAE classification on epilepsies and epileptic syndromes (2017) maintain, even modified the term of developmental and epileptic encephalopathies, as epileptic syndromes where \u201cthe abundant epileptiform activity interferes with development resulting in cognitive slowing and often regression, and sometimes is associated with psychiatric and behavioral consequences\u201d. The epileptiform activity can induce regression while a previous normal development or developmental delay prior to epilepsy onset. \u201cA key component of the concept is that amelioration of the epileptiform activity may have the potential to improve the developmental consequences of the disorder\u201d [3].<br \/>\nMany\tdevelopmental\tand\tepileptic encephalopathies have genetic etiology and \u201calso have developmental consequences arising directly from the effect of the genetic mutation, in addition to the effect of the frequent epileptic activity on development\u201d [3]. There were debates as if the seizures and\/or interictal discharges themselves are responsible for the<br \/>\ncognitive decline in DS [7].<br \/>\nThere are several reports where almost all patients with DS showed severe to moderate mental deficit [8], but deterioration was not observed [7].<br \/>\nA large study on children with typical DS, where they have been assessed for cognitive development, showed that mental retardation worsened with age, but there were no loss of abilities and children progressed slow but constant along the first decade; these evidences preceded the new defined term of developmental and epileptic encephalopathy [9].<br \/>\nEpidemiology<br \/>\nDS is found in 1 per 20,000 to 1 per 40,000 members of a population [7]. Recent studies have shown an overall incidence = 1:28 600 [10]. An epidemiological study showed an incidence of DS around 1:22,000 [11].<br \/>\nDS was reported being responsible for 1.4% of all epileptic children age under 15 years, in a study realized in Navara, Spain in 2007 [12].<br \/>\nA male-to-female ratio of 1.27 to 1 was reported [10].<br \/>\nFamily history<br \/>\nA family history of febrile seizures or epilepsy in relatives of DS children, was identified being present in 15-35% of cases, the most common phenotype seen is GEFS+ [4]. Monozygotic twins and rarely in zygotic twins have been found in DS families. There are few reports of two or more affected children in the same family. Mosaicism is reported in 7% of families with DS [12].<br \/>\nDS could appear both in families with positive history of febrile seizures and de novo SCN1A mutations, suggesting a polygenic mode of inheritance and modifier genes such as SCN9A was related to the phenotype severity [13].<br \/>\nPersonal history<br \/>\nNeurological status is normal at onset. There is no significant neurological personal history. Could be present though antecedents of sufferance during pregnancy and delivery in 22\u201340% of the cases [14].<br \/>\nThere were identified other rare associated disorders: Rud syndrome (AR, congenital ichthyosis, epilepsy, dwarfism, sexual infantilism, polyneuritis, and macrocytic anemia), type I neurofibromatosis [7], congenital cardiac defect, growth hormone deficit, and hemophilia [15].<br \/>\nNeurological development, prior seizures onset, is apparently normal, even in the patients with pathological history.<br \/>\nEpilepsy onset<br \/>\nSeizures onset is around 5 &#8211; 8 months (ranges from 2 to 10 months); onset after the age of 1 year has been exceptionally reported, the seizure onset, up to age of 15 months may occur [14].<br \/>\nTypically, the first seizure is clonic, bilateral, or unilateral, triggered by fever and lasting longer than a simple febrile seizure (longer than 20 minutes) [7,14]. In 25% &#8211; 49% of the cases, seizure evolve into status epilepticus. There are also reported the onset seizures occurring without fever in 28% &#8211; 61% of the<br \/>\npatients [7,14].<br \/>\nAfebrile seizures occur though during an infectious episode, after exposure to warm water (after bath) or after a vaccination later, these children still associate febrile triggered seizures. Seizures triggered by vaccination occur earlier than fever triggered seizures but, it was proved that vaccination itself had no impact on the developmental outcome [15].<br \/>\nSometimes, isolated focal myoclonic episodes could be present in prior days or even weeks before the first convulsive seizure.<br \/>\nThe first convulsive episode is often evaluated as an accidental, isolated seizure or a simple febrile seizure, that\u2019s why usually no investigations are performed, and no treatment is given. Later, usually after 2 weeks (or up to 2 months), another convulsive episode triggered by fever occur. In time, between the age of 1 to 4 years, other seizure types occur, associated with developmental delay.<br \/>\nType of seizures<br \/>\nIn DS seizures are polymorphous:<br \/>\n1.\tconvulsive seizures \u2013 generalized onset motor seizures \u2013 clonic or tonic\u2013clonic, or alternating unilateral clonic seizures. Convulsive seizures are most of them focal to bilateral; usually there is a brief focal onset, or they are \u2018\u2018unstable from one hemisphere to the contralateral\u201d [16]. In younger patients dominate unilateral clonic seizures that tend to be prolonged to status epilepticus; in older patients, seizures are shorter, with unilateral motor semiology (clonic or tonic-clonic) but associated with contralateral tonus changes and, often with post-ictal transitory hemiparesis. Unilateral clonic seizures can be on either side or alternating pattern \u2013 that is a clue for the diagnosis of DS [15].<br \/>\n2.\tmyoclonic seizures \u2013 appear after the age of 1 year, up to the age of 5 years (mean age 1.5 years), bilateral, sometimes barely discernible. It may associate an atonic phase \u201chead nodding\u201d. Myoclonic seizures can appear isolated or grouped in bursts of 1 \u2013 3 sec. Sometimes they are present only with minutes or hours in the preceding of a convulsive seizure. In DS children myoclonic seizures could be triggered by photic stimulation (light intensity variation, eyes closure, or patterns). Seldom, myoclonic status could appear and it lasts more than 24 hours.<br \/>\n3.\tatypical absences and obtundation status \u2013 the onset is between 4 months and 6 years associated with myoclonic seizures. They could appear later, in childhood, up to the age of 12 years. The absences seizures last from 3 \u2013 10 sec, and are characterized by impaired awareness; they are isolated or accompanied by myoclonias, \u201ceye fluttering\u201d, \u201chead nodding\u201d. The \u201cobtundation status\u201d is a characteristic symptom for DS patients, present in 30 to 40% of them and it could last for hours or even several days. It is sustained by eye closure, pattern fixation (TV screen, \u201cdotted lines on the walls\u201d). Strong sensorial stimulation could improve the awareness but, not completely [7,16].<br \/>\n4.\tfocal seizures or focal to bilateral seizures &#8211; occur in up to 78,6% of patients [7]. The onset is between age of 4 months to 4 years. They are focal seizures with motor onset (tonic versive or focal clonic limited to a limb or part of the face, automatisms, eyelid myoclonias or limb myoclonias) or with more complex semiology, including significant autonomic symptoms (pallor, cyanosis, respiratory changes, drooling, sweating) [7,14].<br \/>\n5.\ttonic seizures &#8211; are not characteristic for DS but could appear; they resemble the axial tonic seizures from<br \/>\nLennox-Gastaut syndrome, sometime myoclonyas are associated. Usually they are sporadic [7].<br \/>\nSeizures triggering factors<br \/>\n1.\tIt is a well-known fact that in DS patients, seizures are triggered or exacerbated by external factors, such as:<br \/>\n2.\tEnvironmental temperature variations, hot baths;<br \/>\n3.\tInfections, even without fever;<br \/>\n4.\tEnvironmental light and pattern exposure;<br \/>\n5.\tPhysical exercise, that could induce body overheating;<br \/>\n6.\tNoisy environments, music;<br \/>\n7.\tEmotions positive or negative (birthday or new year parties).<br \/>\nSensitivity to these stimuli is present all along the life span, sometimes determines auto- stimulation (simply by eyes closure) [7,14]. The high convulsive susceptibility is considered a factor of pharmacoresistance [15].<br \/>\nDevelopmental and cognitive features<br \/>\nIn the first neuropsychological study of DS patients, performed in Marseille, the global developmental quotient (DQ) declined quickly: to 60 &#8211; 95 in children aged 1 to 3 years and to severe deficit, 25 &#8211; 40 in children older than 6 years. The impairment degree was correlated with the severity of epilepsy at onset (in the first 2 years of life) [15].<br \/>\nMotor development appears to be in normal ranges in the first year of life with a later decline; walking is gained at a normal age but it becomes unsteady; \u201ccrouch gait with increased flexion from hip and knee and dorsiflexion of the ankle in sagittal plane in the stance phase, accompanied by medial femoral torsion, lateral tibial torsion and feet valgus abductus in medial plane\u201d is developed in time [17]. Because of this, periodic orthopedic evaluation it is recommended for DS children.<br \/>\nLanguage is also normal developed in the beginning, but many DS children do not gain the ability to construct elementary sentences; fine motor abilities are also deficient due to segmental myoclonus and poor eye-hand coordination. They are not able to draw a design and could write only using printing letters even when milder cognitive impairment is present [15].<br \/>\nWe could say that persons with DS develop a particular psychological profile (suggesting a frontal lobe disfunction\/ immaturity) characterized by:<br \/>\n\u2013\tlack of attention, with significant impact on learning disabilities that appear later,<br \/>\n\u2013\trestlessness and hyperactivity, impulsivity,<br \/>\n\u2013\tmost of the time they do not listen to adults and are not interested to participate in usual activities related to their age group, sometimes they could develop recalcitrant behavior,<br \/>\n\u2013\tthey have perseverative responses,<br \/>\n\u2013\texecutive function is impaired and have deficient planning,<br \/>\n\u2013\tDS children prefer stereotype activities &#8211; to complete puzzles and watch cartoons repetitively,<br \/>\n\u2013\tsleep disorders are often present [10],<br \/>\n\u2013\tassociated, reduced sensitivity to pain is reported [18],<br \/>\n\u2013\tautistic features are repeatedly reported, language may be less affected in some patients, though. There were reported studies that included psychological evaluation of DS patients, socialization skills assessed using the Vineland scale, were significantly better than communication skills and autistic features previous reported were not confirmed [13].<br \/>\nIn an animal study, the mouse models of DS demonstrated hyperactivity, stereotypic behavior and cognitive deficits from ADHD and autistic spectrum, due to reduced expression of GABAergic interneurons in the forebrain. In mice studies, where SCN1A activity was selectively reduced, the animals did not develop seizures, but cognitive deficits appeared, showing that Nav1.1 dysfunction plays an important role on cognitive decline, independent on seizures severity [13].<br \/>\nComorbidities<br \/>\n1.\tWalking disorder that develops once the walking is acquired, is associated with osteopenia that worsened with patient age. Repeated fractures could appear, also worsened with age, being more prevalent in teenagers and adults comparing with infant and toddlers [18]. For DS patients it is recommended periodic orthopedic evaluation<br \/>\n2.\tCardiac involvement: long Q-T intervals are reported in SCN1A patients; they are related with cardiac arrest in SUDEP. Even heart structure abnormalities were reported. Bradycardia and tachycardia were identified in these patients (13% and 30%, respectively) [19]. For DS patient periodic cardiological evaluation it is mandatory.<br \/>\n3.\tFeeding disorders with appetite disturbances, metabolism and growth issues \u2013 needing periodic nutritional evaluation by a dietician. It has been shown that feeding disorders become more severe after age of 4\u20136 years; it could be a medication side effect, or it is due to Dravet syndrome itself [18].<br \/>\n4.\tProne to frequent infections, like otitis, bronchitis, pneumonia, or chronic infections, there could be associated immunity issues and allergies, aspect that raise the need of periodic allergology and immunology evaluation [18].<br \/>\n5.\tPrecocious puberty was reported in 9% of DS children, same as is delayed puberty (9%), these patients needing periodic endocrinological evaluation also [18]. There are studies showing that DS patients SCN1A-negative were more likely to experience delayed puberty [18,10].<br \/>\n6.\tNephrocalcinosis was another co-morbidity shown to be present in DS patients, raising the need of nephrological evaluation. Nephrocalcinosis was more often reported in patients without SCN1A mutations than in patients with SCN1A mutations [18].<br \/>\n7.\tAutonomic disorders such as temperature dysregulation, was reported in a high proportion of DS patients (80%, according to Villas et al, 2017); it seems to appear around the age of one to three years and it remains steady throughout the older age [18].<br \/>\nTHE COURSE OF THE DISEASE<br \/>\nThere are three stages described in Dravet syndrome:<br \/>\n1.\tthe febrile or diagnostic stage \u2013 in the first year<br \/>\nof life, characterized by prolonged febrile seizures, evolving to status epilepticus; it\u2019s the time when usually, the diagnosis is done [7], [14].<br \/>\n2.\tthe worsening (preferred to \u2018\u2018catastrophic\u2019\u2019) stage<br \/>\n&#8211;\tbetween 1 and 5 years \u2013 it is a period with many seizures and episodes of febrile status epilepticus, behavioral deterioration; it\u2019s the stage when other neurologic signs and symptoms occur;<br \/>\n3.\tthe stabilization stage \u2013 after the age of 5 years,<br \/>\nconvulsive seizures occur mainly during sleep and diminish in frequency and intensity; myoclonic and absence seizures decrease and even can disappear, focal seizures persist or decrease; mental development and behavior tend to improve but cognitive impairment it is still present in variable degree. Worsening of epilepsy and cognitive status could still appear after the age of five.<br \/>\nLosito&#038;Nabout (2017) put things together and set the three stages of Dravet syndrome including cognitive evolution, presented in Table I:<br \/>\nTable I. The course of Dravet syndrome in three stages with the clinical and cognitive states at each stage. (Losito &#038; Nabout, 2017)<\/p>\n<p>First stage or \u201cfebrile stage\u201d (1 \u2013 12 months)<br \/>\nConvulsive seizures, mainly febrile, hemiclonic and long lasting are characteristic for Dravet syndrome<br \/>\nNormal EEG and MRI<br \/>\nNormal psychomotor development but early visual functions impairments are present<br \/>\nSecond stage (12-15 months \u2013 5 years)<br \/>\nPolymorphous resistant seizures: myoclonias, atypical absences, tonic\/clonic focal seizures<br \/>\nGait disturbances<br \/>\nNormal EEG or showing a slowing in the background activity and multifocal epileptiform abnormalities Slowing in cognitive development with attention deficit, behavior disorders and autistic spectrum disorders in some patients<br \/>\nThird stage (>6 years)<br \/>\nPharmacorezistant seizures persisting with few seizures\u2019 free patients<br \/>\nNocturnal seizures might be more frequent than diurnal Persistence of fever sensitivity<br \/>\nDefinite intellectual disability, stagnation without regression Executive function deficit<br \/>\nLanguage output more impaired than comprehension Persistent deterioration of visual function<br \/>\nHattori et al (2008) proposed a risk score for a screening test in children with clinical characteristics of DS [20] \u2013 presented in Table II.<br \/>\nDravet syndrome genetics<br \/>\nMore than 500 mutations have been associated with DS and there are randomly distributed along the SCN1A gene, encoding the a1 subunit of the sodium channel (SCN1A). Up to 70 \u2013 80% of the patients are positive for SCN1A mutation, there were reported  Table II. Risk score for screening test in children suspected of Dravet syndrome<\/p>\n<p>Predictive factors\tRisk score<br \/>\nClinical score<br \/>\n&#8211; Onset \u2264 7 months\t2<br \/>\n&#8211; Total number of seizures \u2265 5\t3<br \/>\n&#8211; Hemiconvulsions\t3<br \/>\n&#8211; Focal seizures\t1<br \/>\n&#8211; Myoclonic seizures\t1<br \/>\n&#8211; Prolonged seizures\t3<br \/>\n&#8211; Hot water-induced seizures\t2<br \/>\nGenetic score<br \/>\n&#8211; SCN1A missense mutation\t1<br \/>\n&#8211; SCN1A truncated mutation\t2<br \/>\nFirst phase:<br \/>\nIf the calculated clinical risk score is \u22656 genetic testing should be considered.<br \/>\nOverall results:<br \/>\nIf the total calculated risk score is \u22657 should be strongly suspected a diagnosis of Dravet syndrome [20].<\/p>\n<p>truncating (40%) and missense mutations (40%), the remaining being splice site mutations (insertions, deletions or changes of the number of nucleotides in the specific site at which splicing takes place during the processing of precursor messenger RNA into mature messenger RNA) [21].<br \/>\nAcute encephalopathy<br \/>\nAcute encephalopathy was defined by Mizuguchi et al., as acute brain dysfunction that is usually preceded by an infection. Impaired consciousness, signs of intracranial pressure, often associated with seizures are the characteristic symptoms. AE has been reported in the literature related to various causes, the most frequent being viral (influenza).<br \/>\nOkumura et al. published a series of 15 Japanese cases in 2012. The authors defined AE as a sudden onset of brain dysfunction usually after an infection and fever. It is characterized by loss of consciousness, alone or associated with seizures, involuntary movement, and behavior disorders lasting more than 24 hours [23].<br \/>\nThe pathophysiologic mechanisms are not fully known. Several hypotheses were suggested like a selective vulnerability of the cerebellum to injury, excitotoxicity and anoxic ischemia induced by barbiturates, mitochondrial dysfunction, inappropriate antiepileptic drug treatment with large doses of benzodiazepines and secondary respiratory depression [23].<br \/>\nMortality in Dravet syndrome<br \/>\nDS is associated with high mortality rate, up to 15% by the age of 20 years [7], 16% die before age of 18 [4]. Sudden unexpected death in epilepsy (SUDEP) is frequent present in DS patients; studies in Dravet mice models showed that SUDEP is related with an increased parasympathetic activity that appears after a convulsive generalized seizure, with secondary lethal bradycardia and electrical ventricular dysfunction. This abnormality has been seen in mice with the SCN1A mutations selectively targeted to affect the brain, but not if the SCN1A mutations were selectively targeted to affect the heart only, and it was proposed the hypothesis that SUDEP is due to an autonomic defect that secondary affect the heart after a seizure [24].<br \/>\nCheah et al (2013) proposed a mechanism of this disorder, a natural decline of Nav1.3 channel expression without increasing of Nav1.1 channel expression that leads to a disinhibition of neuronal circuits and secondary resistant epilepsy with high risk of premature death [25].<br \/>\nBagnall et al (2017) proposed a list of genes associated with sudden unexpected death in epilepsy (SUDEP) [19], presented in Table III.<br \/>\nDIAGNOSIS CRITERIA<br \/>\nILAE, 1983 (at that time still called Severe Myoclonic Epilepsy of Infancy)<br \/>\n1.\tfamily history of epilepsy or febrile convulsions;<br \/>\n2.\tno previous personal history of disease;<br \/>\n3.\tseizures beginning in the first year of life in the<\/p>\n<p>form of generalized or unilateral febrile clonic seizures;<br \/>\n4.\tsecondary appearance of myoclonic jerks and often partial seizures;<br \/>\n5.\tEEG showing bilateral spike-wave (SW) and polyspike-wave (PolySW), photosensitivity and focal abnormalities;<br \/>\n6.\tretarded psychomotor development from the second year of life;<br \/>\n7.\tsimultaneous ataxia, pyramidal signs, and interictal myoclonus;<br \/>\n8.\tresistance to all forms of treatment;<br \/>\n9.\tintellectual deficiency and personality disorders in all affected children.<br \/>\n(Commission on Classification and Terminology of the International League Against Epilepsy, 1989) [26].<br \/>\nILAE, 2010:<br \/>\n1.\tone family history of epilepsy or febrile convulsions is not constant but variable according to the authors (25\u201371%) [26];<br \/>\n2.\tthe initial seizures are not always generalized or unilateral clonic but may be focal or myoclonic; they are not always febrile and the clonic seizures often evolve to status epilepticus;<br \/>\n3.\tnot only myoclonic jerks and focal seizures appear secondarily but also atypical absences and obtundation statuses;<br \/>\n4.\tphotosensitivity may be associated with pattern- sensitivity;<br \/>\n5.\tneurological signs are not always present but are frequently observed: ataxia (60%), pyramidal signs (20%) and interictal myoclonus (36\u2013 85%) [26];<br \/>\n6.\tthe MRI is normal at the onset;<br \/>\n7.\tcognitive deficiency and personality disorders are present in all affected children during the disease, but they are of variable degrees, from slight to severe, and may be detected only at the age when entering elementary school [27,26].<br \/>\nDIFFERENTIAL DIAGNOSIS<br \/>\nDravet syndrome must be differentiated from other childhood epilepsies and epileptic encephalopathies, in order to choose the best management and set the most probable prognosis. Main epileptic syndromes Dravet syndrome need to be differentiated are listed in Table IV.<br \/>\nTransition to adulthood<br \/>\nChildhood-onset epilepsy persisting into adulthood can have one of the three possible outcomes.<br \/>\nWell-controlled epilepsy in cognitively normal patients \u2013 the group of IGE=idiopathic generalized epilepsies from old clasification;<br \/>\nDifficult to treat epilepsy in cognitively normal patients \u2013 most commonly with focal onset &#8211; temporal lobe epilepsy (TLE);<br \/>\nResistant epilepsy associated with cognitive deficits.<br \/>\nPatients with Dravet syndrome survive into adulthood. It is essential for neurologists to know Dravet syndrome characteristics for proper management, in this regard a good \u2018transition\u2019 is important.<br \/>\nTransition has been defined as a \u201cpurposeful planned process that addresses the medical, psychosocial, and educational\/vocational needs of young people with chronic physical and medical conditions as they move from child-centered to adult-oriented health care systems\u201d [28].<br \/>\nA transition clinic could be helpful, there is a place where the patient and family are seen for several<br \/>\nvisits jointly by the adult neurologist together with the pediatric neurologist. Alternately, transition to an adult center that is specialized in rare epilepsies may also be very successful solution.<br \/>\nAlso, adult emergency room physicians need to become involved in the transition process.<br \/>\nConsidering it is a childhood epileptic encephalopathy, Dravet syndrome is under-diagnosed and under-reported in adulthood. The diagnosis should be considered in all adults presenting with infantile-onset resistant epilepsy, by reevaluation of childhood history and SCN1A testing [29].<br \/>\n DS in adulthood<br \/>\nDS seizures in adulthood<br \/>\nGeneralized convulsive seizures, mostly reported as generalized tonic\u2013clonic seizures (GTCS), were the only seizure type observed in almost all the patients [15].<br \/>\nConvulsive status epilepticus had never occurred in any of the patients after age 10 [4].<br \/>\nFever\u2019s impact on seizure frequency and severity is milder than in infancy. Fever-related<br \/>\nseizures in adults do not evolve into SE or seizure clusters [4].<br \/>\nMyoclonic seizures and atypical absences disappear before the age of 20 in up to 93% of patients [4].<br \/>\nPhotosensitivity and pattern sensitivity also showed a tendency to disappear before the age of 20 [4], [8].<br \/>\nNeurologic status in DS adult<br \/>\nCerebellar features: ataxia, dysarthria, intention tremor, and eye movement disorder are more<br \/>\nprominent. Pyramidal symptoms, features of Parkinsonism with bradykinesia, asymmetric rigidity and cogwheeling, non-epileptic myoclonus are present. Orthopedic signs like: kyphosis, kyphoscoliosis, flat feet, or claw feet are present. Minor symptoms during childhood \u2013 worsened during and after adolescence, despite physiotherapy. Walking &#8211; markedly impaired, there is the need for wheelchair. Neurological deterioration continued throughout life in all patients, with further impairment of speech, mobility and<br \/>\nability for daily activities.<br \/>\nMental disability is moderate to severe [4]. Autism spectrum disorders persist in adult patients with DS,<\/p>\n<p>while certain characteristics associated with behavioral problems, such as hyperactivity or the need for using of psychoactive medication, are be less prominent than in childhood [30], [31].<br \/>\nMost of the adult patients live in residential care or at home, with support for daily activities. The oldest age reported for living Dravet patient was 60 years of age [31].<br \/>\nIn adult DS patients, the lack of occipital alpha rhythms on the follow-up EEGs was significantly correlated with a severe mental disability and it is thought that slow EEG background must represent brain dysfunction.<br \/>\nNo SCN1A mutation was related with seizure or mental outcome in adult DS patients.<br \/>\nWHAT DO WE KNOW 40 YEARS LATER (OR, INSTEAD OF CONCLUSIONS)?<br \/>\n1.\tDravet syndrome may be better viewed as a disease of the central nervous system with epileptic and non-epileptic manifestations rather than merely an epilepsy syndrome<br \/>\n2.\tDravet syndrome is not limited to pediatric age<br \/>\n3.\tIt is a resistant form of epilepsy<br \/>\n4.\tEarly diagnosis means the opportunity for a better management and possible a better prognosis<br \/>\n5.\tProper management needs multidisciplinary team and a well-established protocol of coordinated evaluations.<\/p>\n<p>BIBLIOGRAPHY<br \/>\n1.\tDravet, C. Les e\u00b4pilepsies graves de l\u2019enfant. La Vie me\u00b4dicale, 1978; (8): 543-548.<br \/>\n2.\tEpilepsy, C. o. Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia, 1989;30: 389-399.<br \/>\n3.\tScheffer, I., Berkovic, S., Capovilla, G., Connolly, M., French, J., Guilhoto, L. Y-H., Z. ILAE classification of the epilepsies: Posi- tion paper of the ILAE Commission for Classification and Ter- minology. Epilepsia, 2017;4(58):512-521. doi:10.1111\/epi.13709<br \/>\n4.\tAkiyama, M., Kobayashi, K., Yoshinaga, H., &#038; Y, O. A long term- follow-up study of Dravet syndrome up to adulthood. Epilepsia, 2010; 6(51):1043 &#8211; 1052. doi:10.1111\/j.1258-1167.2009.02466.x<br \/>\n5.\tEngel J.Jr. A Proposed Diagnostic Scheme for People with Epilep- tic Seizures and with Epilepsy: Report of the ILAE Task Force on Classification and Terminology. Epilepsia, 2001;16(42): 796-803.<br \/>\n9.\tNabbout, R., Chemaly, N., Chipaux, M., Barcia, G., Bouis, C., Dubouch, C. Chiron, C. Encephalopathy in children with Dravet syndrome is not a pure consequence of epilepsy. Orphanet Journal of Rare Diseases, 2013;(8):176. doi:10.1186\/1750-1172-8-176<br \/>\n10.\tZuberi, S., &#038; Sisodiya, S. (2015). Dravet Syndrome UK. Retrieved from Dravet Syndrome Family Guide: https:\/\/www.dravet.org.uk\/ CMSUploads\/Dravet_Family_Guide_Booklet.pdf.<br \/>\n11.\tBayat, A., Hjalgrim, H., &#038; M\u00f8ller, R.. The incidence of SCN1A- related Dravet syndrome in Denmark is 1:22,000: a population- based study from 2004 to 2009. Epilepsia, 2015; 4(56):e36-9. doi: 10.1111\/epi.12927<br \/>\n12.\tDura-Trave, T., Yoldi-Petri, M., &#038; Gallinas-Victoriano, F. Epilepsy in children in Navarre, Spain: epileptic seizure types and epileptic syndromes. J Child Neurol 2007; (22): 823-828.<br \/>\n13.\tConnolly, M. B. Dravet Syndrome: Diagnosis and Long-Term Co- urse. Can J Neurol Sci., 2016; 43: S3-S8. doi:10.1017\/cjn.2016.243<br \/>\n14.\tRagona, F., Brazzo, D., DeGiorgia, I., Morbia, I., Freria, E., Te- utonico, F. Granata, T. Dravet syndrome: Early clinical manifes- tations and cognitive outcome in 37 Italian patients. Brain and Development, 2010;32(1):71-77. doi:https:\/\/doi.org\/10.1016\/j. braindev.2009.09.014<br \/>\n15.\tDravet, C. The core Dravet syndrome phenotype. Epilepsia, 2011; 52(Suppl.2): 3-9. doi:10.1111\/j.1528-1167.2011.02994.x<br \/>\n16.\tBureau M, D. B. Electroencephalographic characteristics of Dra- vet syndrome. Epilepsia, 2011; 52(Suppl.2):13-23. doi:10.1111\/ j.1528-1167.2011.02996.x<br \/>\n17.\tRodda, J., Scheffer, I., McMahon, J., Berkovic, S., &#038; Graham,<br \/>\nH. Progressive Gait Deterioration in Adolescents With Dravet Syndrome. Arch Neurol, 2012;7(69): 873-878. doi:10.1001\/arch- neurol.2011.3275<br \/>\n18.\tVillas, NMM. Dravet syndrome:  Characteristics,  comorbiditi- es, and caregiver concerns. Epilepsy &#038; Behavior, 2017;74:81-86. doi:http:\/\/dx.doi.org\/10.1016\/j.yebeh.2017.06.031<br \/>\n19.\tBagnall, R., Crompton, D., &#038; Semsarian, C. Genetic Basis of Sud- den Unexpected Death in Epilepsy. Front. Neurol., 2017; 8: 348. doi:10.3389\/fneur.2017.00348<br \/>\n20.\tHattori, J., Ouchida, M., Ono, J., Miyake, S., Maniwa, S., Mimaki, N., &#038; Ohtsuka, Y. A screening test for the prediction of Dravet syndrome before one year of age. Epilepsia, 2008; 49(4): 626-633. doi:10.1111\/j.1528-1167.2007.01475.x<br \/>\n 21.\tMarini, C., Scheffer, I., Nabbout, R., Sulsb, A., De Jonghe, P., Zara, P., &#038; Guerrini, R. The genetics of Dravet syndrome. Epilepsia, 2011;Suppl,2(52):24-29. doi:10.1111\/j.1528-1167.2011.02997.x<br \/>\n22.\tMizuguchi M. Influenza encephalopathy and related neuropsychi- atric syndromes. Influenza and Other Respiratory Viruses. 2013, 7(Suppl. 3): 67\u201371. DOI:10.1111\/irv.12177. www.influenzajour- nal.com<br \/>\n23.\tThi Thu Hang,T.T. Acute encephalopathy in Dravet syndrome:Case reports and literature review. Neurology Asia, 2016;2(21):181-185.<br \/>\n24.\tKalume F, Westenbroek RE, Cheah CS, Yu FH, Oakley JC, Sche- uer T, Catterall WA. Sudden unexpected death in a mouse model of Dravet syndrome. J Clin Invest. 2013 Apr;123(4):1798-808. doi: 10.1172\/JCI66220. Epub 2013 Mar 25. ;<br \/>\n25.\tCheah, C., Westenbroek, R., Roden, W., Kalume, F., Oakley, J., Jan- sen, L., &#038; Catterall, W. Correlations in timing of sodium channel expression, epilepsy, and sudden death in Dravet syndrome. Chan- nels (Austin), 2013; 7(6): 468-72. doi:doi: 10.4161\/chan.26023<br \/>\n26.\tDravet C. Dravet syndrome history. Developmental Medicine &#038; Child Neurology 2011, 53 (Suppl. 2): 1\u20136. DOI: 10.1111\/j.1469- 8749.2011.03964.x<br \/>\n27.\tICNApedia. (2018, May 06). http:\/\/icnapedia.org\/wiki\/wiki\/2750. Retrieved December 09, 2018, from http:\/\/icnapedia.org: http:\/\/ icnapedia.org\/wiki\/wiki\/2750.<br \/>\n28.\tRajendran, S., &#038; Iyer, A. Epilepsy: addressing the transition from pediatric to adult care. Adolesc Health Med Ther., 2016;7:77-78. doi:[10.2147\/AHMT.S79060]<br \/>\n29.\tScheffer IE, Yue-Hua Zhang, Jansen FE, Dibbens L. Dravet syndrome or genetic (generalized) epilepsy with febrile seizures plus? Brain and Development. 2009 May; 31(5):394-400. doi. org\/10.1016\/j.braindev.2009.01.001.<br \/>\n30.\tBerkvens, J., Veugen, I., Veendrick-Meekes, M., Snoeijen- Schouwenaars, F., Schelhaas, H., Willemsen, M. Aldenkamp, A. Autism and behavior in adult patients with Dravet syndrome (DS). Epilepsy Behav., 2015; 47: 11-6. doi:10.1016\/j.yebeh.2015.04.057.<br \/>\n31.\tCatarino, C., Liu, J., Liagkouras, I., Gibbons, V., Labrum, R., Ellis,<br \/>\nR. Thom M, S. S. Dravet syndrome as epileptic encephalopathy: evidence from long-term course and neuropathology. Brain, 2011; 134: 2982-3010. doi:10.1093\/brain\/awr129<br \/>\n<\/p>","protected":false},"excerpt":{"rendered":"<p>SUMMARY Dravet syndrome was described 40 years ago (1978) by Charlotte Dravet under the name of severe myoclonic epilepsy in infancy (SMEI). It is an epileptic encephalopathy characterized by seizures, beginning in the first year of life in the form of prolonged febrile seizures; in a child with no previous personal history of neurological disease; [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_exactmetrics_skip_tracking":false,"footnotes":""},"categories":[463,459],"tags":[512],"class_list":["post-3748","post","type-post","status-publish","format-standard","hentry","category-numar-4-vol-2018","category-vol-2018","tag-mihaela-adela-vintan"],"_links":{"self":[{"href":"https:\/\/snpcar.ro\/en\/wp-json\/wp\/v2\/posts\/3748","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/snpcar.ro\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/snpcar.ro\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/snpcar.ro\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/snpcar.ro\/en\/wp-json\/wp\/v2\/comments?post=3748"}],"version-history":[{"count":3,"href":"https:\/\/snpcar.ro\/en\/wp-json\/wp\/v2\/posts\/3748\/revisions"}],"predecessor-version":[{"id":3751,"href":"https:\/\/snpcar.ro\/en\/wp-json\/wp\/v2\/posts\/3748\/revisions\/3751"}],"wp:attachment":[{"href":"https:\/\/snpcar.ro\/en\/wp-json\/wp\/v2\/media?parent=3748"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/snpcar.ro\/en\/wp-json\/wp\/v2\/categories?post=3748"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/snpcar.ro\/en\/wp-json\/wp\/v2\/tags?post=3748"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}